Focus | Pressing the “Fast-Forward” Button on Internationalization: Shijiazhuang Sihua Pharmaceutical Group’s Guangxiang Pharmaceutical Obtains Customs AEO Advanced Certification


TIME:2025-12-13

【SUMMARY】 On December 10, Shijiazhuang Customs awarded the Advanced Authorized Economic Operator (AEO) Certificate to Hebei Guangxiang Pharmaceutical Co., Ltd. of Shijiazhuang Sihua Pharmaceutical Group, making it the only pharmaceutical company in the province to obtain AEO certification this year. This milestone signifies that Guangxiang Pharmaceutical has officially been recognized as an enterprise with the highest credit rating under customs supervision.

On December 10, Shijiazhuang Customs awarded the Advanced Authorized Economic Operator (AEO) Certificate to Hebei Guangxiang Pharmaceutical Co., Ltd., a subsidiary of Shijiazhuang Sihua Pharmaceutical Group, making it the only pharmaceutical company in the province to obtain AEO certification this year. This milestone signifies that Guangxiang Pharmaceutical has officially joined the ranks of customs’ highest-credit-rated enterprises.

According to available information, the Authorized Economic Operator (AEO) is a trade security and facilitation framework promoted by the World Customs Organization. As the highest level of customs credit rating awarded to enterprises, the AEO Advanced Certification is often referred to as a “green pass” for global international trade. Customs authorities certify enterprises that demonstrate high compliance with laws and regulations, strong creditworthiness, and robust security standards, enabling them to enjoy streamlined procedures and preferential treatment both domestically and internationally. Through AEO mutual recognition agreements, exports from AEO-certified enterprises in China to partner countries or regions can benefit from expedited customs clearance, thereby reducing trade costs.

As one of China’s leading enterprises in the R&D, production, and export of chemical APIs, Guangxiang Pharmaceutical has, in recent years, closely aligned its efforts with evolving domestic and international market demands by continuously tackling challenges in quality enhancement and green manufacturing. Leveraging new technologies such as continuous-flow microreactors and continuous crystallization, the company has successfully resolved numerous common and critical technical bottlenecks in the production of flagship products like caffeine and metronidazole, optimized its manufacturing processes, implemented end-to-end green management across the entire value chain, and significantly improved product yield and quality metrics. As a result, its product quality now rivals the industry’s cutting-edge standards and has earned widespread recognition in international markets.

Zhu Shujie, Chairman of Guangxiang Pharmaceutical, stated: “Our key products—including caffeine, theophylline, aminophylline, metronidazole, and nifedipine—have successively obtained national GMP certification as well as international certifications such as BRC, FSSC 22000, KOSHER, and HALAL. In 2024, we were awarded Cangzhou City’s first carbon footprint certification, and in 2025 our caffeine products successfully passed EU CEP certification. These achievements have strongly supported the expansion of our export business across all five continents, with our products now sold in more than 60 countries and regions worldwide, continuously enhancing our international competitiveness and brand influence.” Currently, Guangxiang Pharmaceutical’s flagship product, caffeine, has become one of the leading suppliers in the global premium market.

“As overseas markets continue to expand, businesses and their customers are placing ever-higher demands on customs clearance efficiency and logistics timeliness, making the application for AEO Advanced Certification increasingly urgent,” said Zhu Shujie. He added that, throughout the credit-building and certification process, Shijiazhuang Customs provided comprehensive guidance and support, helping the company successfully obtain the Customs AEO Advanced Certification. This not only broadened the company’s network of international trade partners but also accelerated its global expansion, facilitating a shift from “product export” to “brand export” and further bolstering its confidence in going global.

In the increasingly competitive global marketplace, the Customs AEO Advanced Certification has become a “golden brand” for foreign trade. “By combining this certification with preferential measures such as advance customs declaration and priority processing, companies have seen a substantial reduction in customs clearance waiting times and an estimated decrease in logistics costs of nearly 10%, which has effectively helped them gain a first-mover advantage in international markets,” said Zhu Shujie. He added that the company’s next step will be to further identify promising market entry points for more exportable products, fully leverage the prestige of the AEO Advanced Certification, and shift its foreign trade operations from “volume-based exports” to “value-driven exports,” thereby making new contributions to the development of Hebei’s pharmaceutical industry and to building Cangzhou into a strong coastal economic city.

Keywords: